[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Special Communication
November 23/30, 2005

Quality, Innovation, and Value for MoneyNICE and the British National Health Service

Author Affiliations
 

Author Affiliations: National Institute for Clinical Excellence, London, England (Drs Pearson and Rawlins); Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Mass (Dr Pearson); and Wolfson Unit of Clinical Pharmacology, University of Newcastle, Newcastle upon Tyne, England (Dr Rawlins).

JAMA. 2005;294(20):2618-2622. doi:10.1001/jama.294.20.2618
Abstract

The National Institute for Health and Clinical Excellence (NICE) was established as a part of the British National Health Service in 1999 to set standards for the adoption of new health care technologies and the management of specific conditions. In doing so it was required explicitly to take into account both clinical effectiveness and cost-effectiveness. This article describes how NICE has responded to the challenge and considers whether its experience of balancing quality, innovation, and value for money holds policy lessons for the United States.

×